These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37462782)

  • 1. Progress in the Understanding of Estrogen Receptor Alpha Signaling in Triple-Negative Breast Cancer: Reactivation of Silenced ER-α and Signaling through ER-α36.
    Al-Kabariti AY; Abbas MA
    Mol Cancer Res; 2023 Nov; 21(11):1123-1138. PubMed ID: 37462782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
    Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
    J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer.
    Zhao Y; Deng C; Lu W; Xiao J; Ma D; Guo M; Recker RR; Gatalica Z; Wang Z; Xiao GG
    Mol Med; 2011; 17(11-12):1233-41. PubMed ID: 21826373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells.
    Li G; Zhang J; Jin K; He K; Zheng Y; Xu X; Wang H; Wang H; Li Z; Yu X; Teng X; Cao J; Teng L
    Mol Oncol; 2013 Jun; 7(3):611-24. PubMed ID: 23499324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor-α36 is involved in pterostilbene-induced apoptosis and anti-proliferation in in vitro and in vivo breast cancer.
    Pan C; Hu Y; Li J; Wang Z; Huang J; Zhang S; Ding L
    PLoS One; 2014; 9(8):e104459. PubMed ID: 25127034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells.
    Zhang XT; Kang LG; Ding L; Vranic S; Gatalica Z; Wang ZY
    Oncogene; 2011 Feb; 30(7):770-80. PubMed ID: 20935677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen activation of the mitogen-activated protein kinase is mediated by ER-α36 in ER-positive breast cancer cells.
    Zhang X; Deng H; Wang ZY
    J Steroid Biochem Mol Biol; 2014 Sep; 143():434-43. PubMed ID: 24973581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer.
    Wang ZY; Yin L
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():193-206. PubMed ID: 25917453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.
    Tong JS; Zhang QH; Wang ZB; Li S; Yang CR; Fu XQ; Hou Y; Wang ZY; Sheng J; Sun QY
    PLoS One; 2010 Nov; 5(11):e15408. PubMed ID: 21079811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.
    Shi L; Dong B; Li Z; Lu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Wang Z; Xie Y
    J Clin Oncol; 2009 Jul; 27(21):3423-9. PubMed ID: 19487384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-independent effects of ER-α36 in ER-negative breast cancer.
    Zhang J; Li G; Li Z; Yu X; Zheng Y; Jin K; Wang H; Gong Y; Sun X; Teng X; Cao J; Teng L
    Steroids; 2012 May; 77(6):666-73. PubMed ID: 22402113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the understanding of the structure and function of ER-α36,a novel variant of human estrogen receptor-alpha.
    Rao J; Jiang X; Wang Y; Chen B
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):231-7. PubMed ID: 21888973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative profiles of the mRNAs of ER-alpha and its novel variant ER-alpha36 in breast cancers and matched normal tissues.
    Zheng Y; Zhang J; Xu ZZ; Sheng JM; Zhang XC; Wang HH; Teng XD; Liu XJ; Cao J; Teng LS
    J Zhejiang Univ Sci B; 2010 Feb; 11(2):144-50. PubMed ID: 20104649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.
    Zhu L; Zou J; Zhao Y; Jiang X; Wang Y; Wang X; Chen B
    J Exp Clin Cancer Res; 2018 Jun; 37(1):123. PubMed ID: 29940998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity.
    Zhang X; Wang ZY
    Endocrinology; 2013 Jun; 154(6):1990-8. PubMed ID: 23546601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
    Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
    Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.
    Wang Z; Zhang X; Shen P; Loggie BW; Chang Y; Deuel TF
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9063-8. PubMed ID: 16754886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas.
    Lee LM; Cao J; Deng H; Chen P; Gatalica Z; Wang ZY
    Anticancer Res; 2008; 28(1B):479-83. PubMed ID: 18383888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ER-α36-mediated rapid estrogen signaling positively regulates ER-positive breast cancer stem/progenitor cells.
    Deng H; Zhang XT; Wang ML; Zheng HY; Liu LJ; Wang ZY
    PLoS One; 2014; 9(2):e88034. PubMed ID: 24558373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.